secwatch / observer
8-K filed May 21, 2026, 4:39 PM ET ticker PTAC CIK 0002099095
other material confidence high sentiment neutral materiality 0.40

Patriot Acquisition Corp. closes partial over-allotment, raises additional $15M in IPO

Patriot Acquisition Corp./CI

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-060093
form_type
8-K
ticker
PTAC
cik
0002099095
company_name
Patriot Acquisition Corp./CI
filed_at
2026-05-21T20:39:10+00:00
discovered_at
2026-05-21T20:39:33.309546+00:00
generated_at
2026-05-21T20:45:54.486821+00:00
sec_items
["8.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.4
calibrated_materiality_score
0.4
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-060093
json_url
https://secwatch.observer/filing/0001213900-26-060093.json
markdown_url
https://secwatch.observer/filing/0001213900-26-060093.md
text_url
https://secwatch.observer/filing/0001213900-26-060093.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/2099095/000121390026060093/0001213900-26-060093-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/2099095/000121390026060093/ea0291900-8k_patriot.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

EMYB

Embassy Bancorp expands stock repurchase program by additional $5M

Embassy Bancorp, Inc. June 1, 2026, 4:37 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CTXR

Citius Oncology reports Phase 1 combo data: 24% ORR, 33% in endometrial cancer; Phase 2 planned

Citius Pharmaceuticals, Inc. June 1, 2026, 4:30 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NWSA

News Corp repurchased $2.75M in shares on May 29; $276.9M used under $1B program

NEWS CORP June 1, 2026, 6:32 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

RDAC

Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp. June 1, 2026, 6:08 AM ET other_material Items 1.01, 5.03, 5.07, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CRM

Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected

Salesforce, Inc. June 1, 2026, 4:43 PM ET other_material Items 5.07, 5.02, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

LXU

LSB Industries accelerates Pryor, OK turnaround start to May 28, 2026

LSB INDUSTRIES, INC. June 1, 2026, 4:35 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

SMC

Summit Midstream Corporation announces inaugural $35 million stock repurchase program

Summit Midstream Corp June 1, 2026, 4:31 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-060093

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.